Incidence and risk factors for delayed structural changes in Pipeline Embolization Devices

View at publisher
Authors: Clint A. Badger, Souvik Singha, Huanwen Alvin Chen, Matthew W. Arnold, Najme Hosseini, Rosy Linda Njonkou-Tchoquessi, Mohamed Ahmed Labib, Shyam C. Majmundar, Jacob Cherian, Dheeraj Gandhi, T Miller
Cited by: 1
References: 14

Abstract

BACKGROUND: Flow-diverting stents have transformed the management of intracranial aneurysms, but delayed structural changes of these devices, or delayed braid deformation (DBD), may compromise the parent vessel and increase thromboembolic risk. Data on the incidence, evolution, and predictors of DBD remain limited. METHODS: We retrospectively analyzed all Pipeline Embolization Device (PED) treatments for intracranial aneurysms at our institution from November 2011 to April 2024. Patients without follow-up imaging or treatment with other flow diverters were excluded. Demographic, aneurysm, and procedural variables were collected, including age, vessel-device size mismatch, and intraprocedural vasodilator use. Follow-up imaging was reviewed for DBD, parent-vessel narrowing, and angiographic or clinical sequelae. Multivariable logistic regression identified independent predictors. RESULTS: Among 566 PED treatments, DBD occurred in 59 (10.4%). Most cases were mild (≤49% luminal narrowing), but six (10.2%) showed ≥50% compromise, and two required balloon angioplasty for symptomatic flow limitation. Independent predictors included younger age (OR 1.51 per 10 year decrease, P

Fields of Study & Subjects

Intracranial Aneurysms: Treatment and Complications Cerebrovascular and Carotid Artery Diseases Moyamoya disease diagnosis and treatment

Publication details

Journal / source
Journal of NeuroInterventional Surgery
Publisher
BMJ
Pages
jnis–2026
Publication date
9 April 2026
Language
EN